SIR Douglas Flint CBE has been appointed as the new Chairman of the Royal Marsden NHS Foundation Trust and the Royal Marsden Cancer Charity.

Douglas, who has been a trustee of The Royal Marsden Cancer Charity since 2017, will succeed Charles Alexander CBE when his six-year term expires in November.

The Royal Marsden Cancer Charity exists solely to support The Royal Marsden, a world leading cancer centre.

Douglas said:

“I am proud of my involvement with the Royal Marsden Cancer Charity, and through this I have learned so much about the work of the hospital and its amazing staff.

“I found the experience both humbling and inspiring; commitment to excellence, empathy for those who receive their care, pride at all levels of the hospital in what they do, and the quiet but real contribution that is made to basic research and to clinical excellence for the benefit of current patients and future generations.”

Douglas had two long directing careers. With the international accounting firm KPMG, he trained as a chartered accountant and became a partner in 1988, specializing in banking, multinational financial reporting, treasury and securities trading, group reorganizations and litigation assistance.

He then joined HSBC in September 1995 as Group Chief Financial Officer and was appointed Group Chairman of HSBC Holdings plc in 2010, retiring in 2017 after 22 years of service. In 2018, he was honored with a knighthood in recognition of his services to the financial industry.

Douglas is currently chairman of two UK boards: abrdn plc, one of the largest UK-based asset management groups; and IP Group plc, which helps create, build and support exceptional intellectual property-based companies. During his career, he has gained valuable experience through a varied portfolio of non-executive directors in the private and charitable sectors.

Antonia Dalmahoy, chief executive of the Royal Marsden Cancer Charity, said:

“Douglas’ breadth of business experience and his passion for The Royal Marsden and The Royal Marsden Cancer Charity will be of immense value to us all.

“I would also like to take this opportunity to thank Charles Alexander CBE. Charles’ contribution has enabled the Trust to go further and faster in improving the quality of life and survival of patients locally and globally. through its support for treatment, care and research.

“Under his chairmanship, the Royal Marsden Cancer Charity has also excelled in supporting patients and staff at the Trust, supporting the Trust through the pandemic and developing the wonderful new Oak Cancer Center at the Sutton site. My deepest gratitude and thanks to Charles for his dedication and hard work.

Douglas and Charles will work together over the next few months before Douglas assumes the role of Chairman effective December 1, 2022.